Double beta-lactam therapy in the immunocompromised host.
D000617:Aminoglycosides / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D009503:Neutropenia / Q000150:complications; D018805:Sepsis / Q000150:complications / Q000188:drug therapy; D047090:beta-Lactams
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D047090:beta-Lactams